Dr. James Pearl, MD

NPI: 1417959206
Total Payments
$83,324
2024 Payments
$13,900
Companies
24
Transactions
242
Medicare Patients
1,240
Medicare Billing
$73,606

Payment Breakdown by Category

Other$71,150 (85.4%)
Travel$4,829 (5.8%)
Consulting$4,044 (4.9%)
Food & Beverage$3,247 (3.9%)
Education$54.05 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $71,150 45 85.4%
Travel and Lodging $4,829 39 5.8%
Consulting Fee $4,044 2 4.9%
Food and Beverage $3,247 151 3.9%
Education $54.05 5 0.1%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $81,812 141 $0 (2024)
GlaxoSmithKline, LLC. $240.61 23 $0 (2018)
Boehringer Ingelheim Pharmaceuticals, Inc. $189.96 10 $0 (2019)
Sunovion Pharmaceuticals Inc. $141.82 12 $0 (2019)
Respiratory Technologies, Inc. $83.38 3 $0 (2017)
BOSTON SCIENTIFIC CORPORATION $82.38 3 $0 (2018)
United Therapeutics Corporation $79.64 3 $0 (2021)
Merck Sharp & Dohme Corporation $78.42 5 $0 (2019)
Mallinckrodt LLC $75.17 3 $0 (2018)
ADVANCED RESPIRATORY, INC $72.45 4 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $13,900 19 AstraZeneca Pharmaceuticals LP ($13,900)
2023 $11,229 12 AstraZeneca Pharmaceuticals LP ($11,229)
2022 $21,691 33 AstraZeneca Pharmaceuticals LP ($21,691)
2021 $10,983 16 AstraZeneca Pharmaceuticals LP ($10,964)
2020 $5,340 10 AstraZeneca Pharmaceuticals LP ($5,340)
2019 $185.80 11 AstraZeneca Pharmaceuticals LP ($46.34)
2018 $5,646 60 AstraZeneca Pharmaceuticals LP ($5,005)
2017 $14,350 81 AstraZeneca Pharmaceuticals LP ($13,637)

All Payment Transactions

242 individual payment records from CMS Open Payments — Page 1 of 10

Date Company Product Nature Form Amount Type
11/04/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug), AIRSUPRA Education In-kind items and services $22.52 General
Category: Respiratory
10/29/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,250.00 General
Category: Respiratory
10/02/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $950.00 General
Category: Respiratory
09/04/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $925.00 General
Category: Respiratory
08/28/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Travel and Lodging In-kind items and services $259.96 General
Category: Respiratory
07/01/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,800.00 General
Category: Respiratory
06/25/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $81.03 General
Category: Respiratory
06/25/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Travel and Lodging In-kind items and services $60.30 General
Category: Respiratory
06/12/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,350.00 General
Category: Respiratory
06/03/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Travel and Lodging In-kind items and services $41.54 General
Category: Respiratory
05/03/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,400.00 General
Category: Respiratory
04/10/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,400.00 General
Category: Respiratory
03/27/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $18.44 General
Category: Respiratory
03/27/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Travel and Lodging In-kind items and services $17.42 General
Category: Respiratory
03/27/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $0.65 General
Category: Respiratory
03/15/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Travel and Lodging In-kind items and services $29.48 General
Category: Respiratory
03/15/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $16.71 General
Category: Respiratory
03/12/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $150.00 General
Category: Respiratory
02/13/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $126.82 General
Category: Respiratory
12/12/2023 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $300.00 General
Category: Respiratory
11/30/2023 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,350.00 General
Category: Respiratory
11/16/2023 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $950.00 General
Category: Respiratory
11/14/2023 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Travel and Lodging In-kind items and services $36.68 General
Category: Respiratory
10/27/2023 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Education In-kind items and services $6.23 General
Category: Respiratory
09/13/2023 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,700.00 General
Category: Respiratory

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 256 447 $48,001 $17,640
2022 7 362 549 $56,637 $23,045
2021 7 328 509 $50,025 $21,321
2020 7 294 400 $32,289 $11,600
Total Patients
1,240
Total Services
1,905
Medicare Billing
$73,606
Procedure Codes
30

All Medicare Procedures & Services

30 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 105 235 $33,560 $10,647 31.7%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 29 56 $6,559 $3,347 51.0%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 16 24 $4,104 $2,030 49.5%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 15 25 $1,614 $949.25 58.8%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Facility 2023 38 52 $1,092 $323.52 29.6%
94729 Test to examine how well the lungs exchange gases Facility 2023 26 27 $540.00 $175.50 32.5%
94010 Test to measure expiratory airflow and volume Facility 2023 27 28 $532.00 $167.94 31.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 125 229 $27,900 $10,668 38.2%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 26 52 $8,606 $4,020 46.7%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 30 61 $7,004 $3,201 45.7%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 20 20 $6,680 $2,689 40.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 11 11 $1,929 $850.67 44.1%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Facility 2022 99 117 $2,340 $733.03 31.3%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 15 23 $1,458 $666.52 45.7%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Office 2022 36 36 $720.00 $216.75 30.1%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 101 198 $22,968 $9,849 42.9%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 25 61 $10,004 $4,879 48.8%
99205 New patient outpatient visit, total time 60-74 minutes Facility 2021 25 25 $8,275 $3,289 39.8%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 17 22 $2,486 $1,225 49.3%
93010 Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report Facility 2021 105 128 $2,560 $795.34 31.1%
99441 Physician telephone patient service, 5-10 minutes of medical discussion Facility 2021 18 30 $1,950 $644.04 33.0%
99212 Established patient outpatient visit, total time 10-19 minutes Facility 2021 11 18 $1,242 $477.70 38.5%
93010 Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report Office 2021 26 27 $540.00 $162.50 30.1%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 74 105 $12,148 $2,994 24.6%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2020 12 17 $8,534 $2,966 34.8%

About Dr. James Pearl, MD

Dr. James Pearl, MD is a Critical Care Medicine healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1417959206.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Pearl, MD has received a total of $83,324 in payments from pharmaceutical and medical device companies, with $13,900 received in 2024. These payments were reported across 242 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($71,150).

As a Medicare-enrolled provider, Pearl has provided services to 1,240 Medicare beneficiaries, totaling 1,905 services with total Medicare billing of $73,606. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.

Practice Information

  • Specialty Critical Care Medicine
  • Other Specialties Pulmonary Disease
  • Location Salt Lake City, UT
  • Active Since 08/11/2005
  • Last Updated 09/15/2021
  • Taxonomy Code 207RC0200X
  • Entity Type Individual
  • NPI Number 1417959206

Products in Payments

  • BREZTRI (Drug) $57,620
  • BEVESPI AEROSPHERE (Drug) $13,536
  • BREZTRI AEROSPHERE (Drug) $5,340
  • FASENRA (Drug) $4,952
  • SYMBICORT (Drug) $168.32
  • AIRSUPRA (Drug) $152.14
  • NUCALA (Biological) $94.48
  • ZERBAXA (Drug) $78.42
  • ACTHAR (Biological) $75.17
  • OFEV (Drug) $73.92
  • The Vest System Model 105 Home Care (Device) $72.45
  • BROVANA (Drug) $61.80
  • AVYCAZ (Drug) $58.31
  • STIOLTO RESPIMAT (Drug) $58.29
  • BREO (Drug) $54.76
  • GENERAL PULMONARY (Device) $53.18
  • Perforomist (Drug) $47.19
  • ORENITRAM (Drug) $46.80
  • BEVYXXA (Drug) $46.31
  • TRELEGY ELLIPTA (Drug) $40.60

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Critical Care Medicine Doctors in Salt Lake City